SOHO 2022: Biology and Treatment of LGL Leukemia

SOHO 2022 Tenth Annual Meeting

T. Loughran

SOHO 2022 Next Questions: Hodgkin Lymphoma

SOHO 2022 Tenth Annual Meeting

N. Bartlett

Next Questions: Mantle Cell Lymphoma

SOHO 2022 Tenth Annual Meeting

K. Maddocks

SOHO 2022 Next Questions: T-Cell Lymphoma

SOHO 2022 Tenth Annual Meeting

S. Iyer

SOHO 2022 Next Questions: Follicular Lymphoma

SOHO 2022 Tenth Annual Meeting

G. Salles

SOHO 2022: What's Next in Aggressive B-Cell Lymphoma?

SOHO 2022 Tenth Annual Meeting

L. Sehn

SOHO 2022 Next Questions: Cellular Therapy

SOHO 2022 Tenth Annual Meeting

K. Komanduri

SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro AUTO H…

SOHO 2022 Tenth Annual Meeting

C. Sauter

SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro CAR T-…

SOHO 2022 Tenth Annual Meeting

M. Kamdar

SOHO 2022: Camidanlumab Tesirine - Updated Efficacy and Safety in Pa…

SOHO 2022 Tenth Annual Meeting

A. Herrera

SOHO 2022: Treating Hodgkin Lymphoma After Brentuximab Vedotin and A…

SOHO 2022 Tenth Annual Meeting

A. Herrera

SOHO 2022: Sequencing Novel Agents in Frontline and Second-Line Trea…

SOHO 2022 Tenth Annual Meeting

A. Moskowitz

Phase 1/2 BRUIN Study - Updated Results on Pirtobrutinib in Previous…

SOHO 2022 Tenth Annual Meeting

J. Cohen

Emerging Treatment Options for MCL

SOHO 2022 Tenth Annual Meeting

J. Ruan

Immunotherapeutic Options for Patients With MCL Who Progress on BTK …

SOHO 2022 Tenth Annual Meeting

J. Cohen

The Role of Targeted Therapies in Frontline Treatment of MCL

Tycel Phillips

Is it Time to Recognize the Biological Heterogeneity of MCL?

SOHO 2022 Tenth Annual Meeting

A. Goy

SOHO 2022: Cost-Effectiveness of Polatuzumab Vedotin in Previously U…

SOHO 2022 Tenth Annual Meeting

J. Burke

SOHO 2022: Results from POLARIX, a Phase III Study of Pola-R-CHP vs.…

SOHO 2022 Tenth Annual Meeting

C. Flowers

SOHO 2022: Managing the Elderly Patient With Aggressive B-cell Lymph…

SOHO 2022 Tenth Annual Meeting

C. Thieblemont

SOHO 2022: CNS Prophylaxis in DLBCL

SOHO 2022 Tenth Annual Meeting

V. Orellana-Noia

SOHO 2022: Treatment of Aggressive B-cell Lymphoma Post-CAR T-Cell T…

SOHO 2022 Tenth Annual Meeting

G. Nowakowski

SOHO 2022: The Emerging Potential of Bispecific Antibodies as Monoth…

SOHO 2022 Tenth Annual Meeting

M. Dickinson

SOHO 2022: Choosing CAR T-Cell Therapy vs. ASCT in R/R Aggressive B-…

SOHO 2022 Tenth Annual Meeting

M. Kamdar

SOHO 2022: Has R-CHOP Really Been Replaced as Initial Therapy of DLB…

SOHO 2022 Tenth Annual Meeting

J. Friedberg

SOHO 2022: Pivotal Results From a Phase I/II Study of Mosunetuzumab …

SOHO 2022 Tenth Annual Meeting

L. Nastoupil

SOHO 2022: Using Biology to Determine Type and Duration of Treatment…

SOHO 2022 Tenth Annual Meeting

P. Kapoor

SOHO 2022: Future Role of Bispecific Antibodies in the Treatment of …

SOHO 2022 Tenth Annual Meeting

E. Budde

SOHO 2022: What Is the Role of Transplantation for FL in the Era of …

SOHO 2022 Tenth Annual Meeting

M. Hamadani

SOHO 2022: Sequencing Therapy in Indolent Lymphoma - Treatment Choic…

SOHO 2022 Tenth Annual Meeting

L. Nastoupil

SOHO 2022: Correlation of TRBC1 by Flow Cytometry With Molecular T-C…

SOHO 2022 Tenth Annual Meeting

T. Dexter

SOHO 2022: Advances in the Treatment of NK/T Cell Lymphoma

SOHO 2022 Tenth Annual Meeting

W. Kim

SOHO 2022: Integrating Novel Agents Into the Management of Cutaneous…

SOHO 2022 Tenth Annual Meeting

P. Allen

SOHO 2022: Novel Treatment Approaches in Relapsed/Refractory PTCL

SOHO 2022 Tenth Annual Meeting

M. Lunning

SOHO 2022: The Next Rational Therapeutic Regimen in Newly Diagnosed …

SOHO 2022 Tenth Annual Meeting

N. Mehta-Shah

SOHO 2022: From Bench to Bedside - A Translational Scientist's Persp…

SOHO 2022 Tenth Annual Meeting

F. Vega

SOHO 2022: CAR T-Cells in Indolent B-Cell Lymphomas

SOHO 2022 Tenth Annual Meeting

J. Abramson

SOHO 2022: Challenging Cases in Rare T-Cell Lymphomas

SOHO 2022 Tenth Annual Meeting

S. Barta

SOHO 2022: Basis for Targeting the Microenvironment in Hodgkin Lymph…

SOHO 2022 Tenth Annual Meeting

C. Steidl

SOHO 2022: CAR T-Cell Therapy in Hodgkin Lymphoma

SOHO 2022 Tenth Annual Meeting

C. Ramos

SOHO 2022: The Next Generation of Novel Agents in Development for Ag…

SOHO 2022 Tenth Annual Meeting

J. Westin